
Omnicom Health has named Tom Schwenger as its new CEO, replacing Dana Maiman. Schwenger brings over 35 years of experience in pharma and healthcare, including leadership roles at Veeva Systems and Accenture. His appointment aims to accelerate growth and innovation, particularly through AI, as the healthcare market rapidly evolves. Schwenger will lead global marketing agencies and work closely with Omnicom Health's chairman to enhance client engagement and drive transformative growth.
Omnicom Group Inc. shares are trading at USD 81.66 with a modest gain of 0.49% as of Nov 02, 2026 21:41 WIB on Pluang. The company’s market cap stands at $22.29 billion, reflecting steady investor interest amid leadership changes. The appointment of Tom Schwenger as CEO of Omnicom Health highlights a strategic push towards innovation and growth in healthcare marketing.